Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BF-200 ALA vs Metvix in Actinic Keratosis
NCT02799069Phase 3Completed
- Sponsor
- Biofrontera
- Start
- Apr 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of aminolevulinic acid 10% gel in actinic keratosis (AK), sponsored by Biofrontera. Started Apr 2008; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02799069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799069.